Filing Details
- Accession Number:
- 0000899243-21-025071
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 18:21:04
- Reporting Period:
- 2021-06-17
- Accepted Time:
- 2021-06-21 18:21:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840574 | Verve Therapeutics Inc. | VERV | Pharmaceutical Preparations (2834) | 824800132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1864116 | Andrew Bellinger | C/O Verve Therapeutics, Inc. 500 Technology Square, Suite 901 Cambridge MA 02139 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-21 | 5,000 | $19.00 | 5,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-06-17 | 21,599 | $0.00 | 21,599 | $19.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 21,599 | 2031-06-16 | No | 4 | A | Direct |
Footnotes
- The option was granted on June 17, 2021. 25% of the shares underlying the option will vest on June 17, 2022, and the remainder are scheduled to vest in equal monthly installments thereafter until June 17, 2025.
Billionaire Hedge Funds
